CORE-OM: The Therapist's Tool for Tracking Overall Clinical Progress

Most clinical outcome measures focus on a single dimension: depression, anxiety, alcohol use. But therapy rarely addresses a single dimension. Patients come with complex, overlapping difficulties, and they improve (or don't) across multiple areas simultaneously.

The Clinical Outcomes in Routine Evaluation, Outcome Measure (CORE-OM) was designed specifically for this reality. Developed by practicing therapists for use in routine clinical settings, it captures psychological distress across four domains in a single 34-item instrument.

The Four Domains

Subjective wellbeing (4 items): How the patient feels overall, including optimism, feeling cared for, and life satisfaction. This domain captures positive states, not just the absence of symptoms.

Problems/symptoms (12 items): Anxiety, depression, physical symptoms, and trauma-related experiences. This is the domain most comparable to disorder-specific measures like the PHQ-9 and GAD-7, but broader in scope.

Functioning (12 items): How well the patient is managing in daily life, including close relationships, social functioning, and general coping. This domain captures what many therapists consider the most clinically important dimension: can the patient do the things that matter to them?

Risk (6 items): Self-harm, suicidal ideation, harm to others, and risk-taking behaviors. These items are critical for clinical safety monitoring but are scored separately from the clinical total.

Items are scored 0–4 on a five-point frequency scale. The total mean score (excluding risk items) provides a single indicator of overall distress, while domain scores allow detailed analysis.

Why the CORE-OM Is Uniquely Suited for Therapy

It measures what therapy actually targets. Therapy doesn't just reduce symptoms. It improves functioning, builds wellbeing, and changes how people relate to themselves and others. The CORE-OM captures all of these dimensions.

It's transdiagnostic. Because the CORE-OM isn't tied to a specific disorder, it works equally well for depression, anxiety, personality difficulties, adjustment disorders, relational problems, and complex presentations that don't fit neatly into a single diagnostic category.

It includes risk monitoring. The six risk items provide ongoing safety monitoring as a built-in feature of routine outcome measurement. This is particularly valuable. It normalizes safety assessment as part of routine practice rather than making it a response to crisis.

It was built for routine clinical use. Unlike instruments originally developed for research (which were later adapted for clinical practice), the CORE-OM was designed from the ground up for therapists to use in their everyday work. It balances psychometric rigor with clinical practicality.

Interpreting Scores

Clinical cutoff: A mean score of 1.0 distinguishes between clinical and non-clinical populations. Patients scoring above 1.0 are in the clinical range.

Reliable change: A change of 0.5 or more in the mean score exceeds measurement error and represents statistically reliable change.

Clinically significant change: Moving from above the clinical cutoff (1.0) to below it, with a change exceeding the reliable change threshold. This is the gold standard for meaningful improvement.

Severity bands:

• 0.0–0.5: Healthy
• 0.5–1.0: Low-level distress
• 1.0–1.5: Mild distress
• 1.5–2.0: Moderate distress
• 2.0–2.5: Moderate-to-severe distress
• 2.5+: Severe distress

The CORE-10: When You Need Something Shorter

The CORE-10 is a 10-item version that extracts the most statistically efficient items from the full CORE-OM. It takes under 2 minutes to complete and correlates highly (r > 0.9) with the full measure.

The CORE-10 works well for session-by-session monitoring when the full 34-item CORE-OM feels too lengthy. A common approach: use the full CORE-OM at intake and discharge (for thorough assessment), and the CORE-10 at every session (for ongoing monitoring).

The CORE-10 includes one risk item (self-harm), maintaining basic safety monitoring capability.

Domain Profiles Tell Richer Stories

The real clinical power of the CORE-OM emerges in the domain-level analysis:

High symptoms, low functioning impairment: The patient is suffering but coping. Treatment might focus on symptom relief while acknowledging the patient's existing coping resources.

Low symptoms, high functioning impairment: The acute symptoms may have resolved but the patient's life hasn't recovered. This pattern is common post-crisis and suggests a focus on behavioral activation, social engagement, and functional rehabilitation.

High risk with moderate overall distress: The total distress score may look manageable, but the risk items signal a need for immediate safety attention. This is why risk is scored separately: it shouldn't be diluted within a global distress score.

Wellbeing improving faster than symptoms: The patient is feeling more hopeful and optimistic even though symptoms persist. This is a positive prognostic sign that can be reflected back to the patient.

Functioning improving faster than symptoms: The patient is getting their life back even before they feel better. Behavioral changes are preceding emotional changes, a pattern consistent with behavioral activation approaches.

Using the CORE-OM for Practice-Level Outcomes

Beyond individual patient tracking, the CORE-OM provides a framework for evaluating your practice's overall effectiveness:

• What percentage of your patients achieve reliable improvement?
• What percentage achieve clinically significant change?
• How do outcomes compare across different presenting problems?
• What's the average trajectory, and how quickly do patients typically improve?

These questions become answerable when you administer the CORE-OM routinely. And the answers can inform service development, training priorities, and clinical supervision.

Practical Implementation

At intake: Full CORE-OM (34 items) establishes a complete baseline and identifies risk.

Every session or every other session: CORE-10 provides ongoing monitoring with minimal burden.

At planned ending: Full CORE-OM again, for comparison with intake and full outcome assessment.

At periodic review (e.g., every 6–8 sessions): Full CORE-OM to reassess the complete profile, particularly if treatment is longer-term.